Medicare Fraud Detection and Deterrence Act of 2025
Summary
HB1784, titled the Medicare Fraud Detection and Deterrence Act of 2025, would amend the Social Security Act to add new anti-fraud and program-integrity requirements for Medicare and other federal health care programs. The bill focuses on three main areas: deactivating certain provider identifiers when an individual or entity is excluded from federal health care programs, requiring Medicare Advantage encounter data to include the ordering or referring provider’s national provider identifier for certain items and services, and requiring claims for certain telehealth services to identify when the furnishing clinician has a contractual or employment relationship with a telehealth company.
The bill also directs the Secretary of Health and Human Services to update standards within 180 days, reject noncompliant Medicare Advantage encounter data, and establish a claims modifier for telehealth services furnished by specified entities. It defines covered items and services broadly enough to include durable medical equipment, prosthetics and orthotics, clinical laboratory tests, diagnostic imaging, and certain home health services. In practical terms, the bill would create additional reporting and validation requirements intended to make it harder for excluded providers or opaque telehealth arrangements to evade detection in Medicare billing and data systems.
Impact
If enacted, the bill would amend titles XI and XVIII of the Social Security Act and would require HHS to revise HIPAA-related identifier standards, Medicare Advantage encounter-data rules, and Medicare telehealth claims processing. It would affect excluded providers and suppliers, Medicare Advantage plans, telehealth companies, physicians and practitioners who contract with them, and HHS oversight functions, including the Office of Inspector General’s exclusion list. The bill would likely increase administrative compliance obligations for plans and providers while giving federal agencies more tools to cross-check exclusions, validate identifiers, and identify potentially abusive billing arrangements.
Sentiment
The available context suggests the bill is framed positively as a fraud-prevention and program-integrity measure, with no recorded committee debate or roll-call votes indicating opposition or support. Its title and structure emphasize detection, deterrence, and enforcement, which typically signals a bipartisan or broadly favorable policy goal centered on protecting Medicare funds. Because there are no transcripts or votes provided, there is no documented public sentiment beyond the bill’s anti-fraud purpose and its referral for committee consideration.
Contention
The main potential points of contention are likely to be administrative burden, implementation complexity, and the scope of new reporting requirements. Medicare Advantage plans may object to mandatory rejection of encounter data for missing or invalid identifiers, while telehealth companies and affiliated clinicians may view the new modifier requirement as burdensome or as singling out virtual-care business models. Another possible issue is the Secretary’s discretion in determining when deactivation is appropriate for certain entity identifiers and in defining what counts as a telehealth company or de minimis in-person services, which could raise concerns about overbreadth or uneven enforcement.